A further modifying factor can be the tumorous nature of the blast cells, as opposite effects have been described in some malignant tumors of neuronal blast cells, such as medulloblastoma where PACAP inhibited proliferation [60] and in retinoblastoma, where decreased cell viability was observed upon PACAP treatment [61]. The gene discussed is ADCYAP1; the disease is medulloblastoma.